MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

17.56 -0.20 (-1.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,567,205
Open 17.65
Bid (Size) 16.60 (300)
Ask (Size) 18.00 (100)
Prev. Close 17.76
Today's Range 17.38 - 17.69
52wk Range 8.625 - 18.07
Shares Outstanding 1,212,301,241
Dividend Yield 2.73%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Generic Pharmaceuticals Stocks Q1 Highlights: Viatris (NASDAQ:VTRS)
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how generic pharmaceutical... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have... 
Via StockStory

Performance

YTD
+40.9%
+40.9%
1 Month
+8.5%
+8.5%
3 Month
+16.8%
+16.8%
6 Month
+34.1%
+34.1%
1 Year
+100.9%
+100.9%

More News

Read More
News headline image
3 Unpopular Stocks We’re Skeptical Of
Via StockStory
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds
Via StockStory
Viatris (NASDAQ:VTRS) Shares Rise as Q1 Earnings Top Estimates ↗
Via Chartmill
News headline image
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
Via StockStory
News headline image
Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings?
Via StockStory
News headline image
This Income Fund Just Completely Exited Its $37 Million Stake in Algonquin Power. Why? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Stock Under $50 to Target This Week and 2 We Avoid
Via StockStory
News headline image
5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
3 Unprofitable Stocks That Fall Short
Via StockStory
News headline image
VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance
Via StockStory
News headline image
Viatris (VTRS) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
News headline image
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
Via StockStory
Topics Artificial Intelligence
News headline image
Earnings To Watch: Viatris (VTRS) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
News headline image
Natera, UFP Technologies, Mettler-Toledo, and Viatris Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy Government Stocks
News headline image
QSM Asset Management Loads Up 611,000 Mobileye Shares ↗
Via The Motley Fool
Topics Economy Regulatory Compliance Supply Chain
News headline image
A Fund Just Bet $5.7 Million on Robert Half -- Is the Staffing Sector Due for a Rebound? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
QSM Asset Management Bets on Beaten-Down Manpower Group With New $5.9 Million Stake in ManpowerGroup ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Via StockStory
News headline image
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Viatris Inc. - Common Stock publicly traded?
Yes, Viatris Inc. - Common Stock is publicly traded.
What exchange does Viatris Inc. - Common Stock trade on?
Viatris Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viatris Inc. - Common Stock?
The ticker symbol for Viatris Inc. - Common Stock is VTRS on the Nasdaq Stock Market
What is the current price of Viatris Inc. - Common Stock?
The current price of Viatris Inc. - Common Stock is 17.56
When was Viatris Inc. - Common Stock last traded?
The last trade of Viatris Inc. - Common Stock was at 07/31/26 04:00 PM ET
What is the market capitalization of Viatris Inc. - Common Stock?
The market capitalization of Viatris Inc. - Common Stock is 21.29B
How many shares of Viatris Inc. - Common Stock are outstanding?
Viatris Inc. - Common Stock has 21B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story